Ciara O'Connell currently serves as the Head of the Novartis Global Corporate Center in Dublin, Ireland, where she leads a diverse team of approximately 1,000 employees. Under her stewardship, the center plays a pivotal role in delivering a wide array of commercial, scientific, and technological...
Ciara O'Connell currently serves as the Head of the Novartis Global Corporate Center in Dublin, Ireland, where she leads a diverse team of approximately 1,000 employees. Under her stewardship, the center plays a pivotal role in delivering a wide array of commercial, scientific, and technological capabilities to the broader Novartis enterprise. With over 20 years of experience in business services strategy, design, implementation, and delivery, Ciara has cultivated a deep expertise in shared services and program management, positioning her as a key driver of operational excellence within the pharmaceutical industry.
At Novartis, Ciara is instrumental in spearheading key projects that enhance the company's global capabilities, ensuring that the Corporate Center remains at the forefront of innovation and efficiency. Her leadership is characterized by a commitment to fostering a multi-cultural and multi-functional environment, which not only enhances collaboration but also drives the successful execution of complex programs. Ciara is a Registered Practitioner in Managing Successful Programmes and has completed advanced training in PRINCE2 and Neuro Linguistic Programming, equipping her with a robust toolkit for navigating the intricacies of project management and organizational development.
Ciara's vision for the Corporate Center emphasizes the importance of integrating scientific and technological advancements into the commercial landscape, ultimately contributing to Novartis's mission of reimagining medicine. Her strategic approach and dedication to continuous improvement have positioned the Dublin center as a vital hub for delivering high-quality advisory services and operational support, reinforcing Novartis's commitment to excellence in the pharmaceutical sector.
